Evidence map›Paper›PMID 27439870›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Mechanism of substrate specificity of phosphatidylinositol phosphate kinases.

Yagmur Muftuoglu, Yi Xue, Xiang Gao, Dianqing Wu, Ya Ha

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. PIP4K attenuates PIP5K lipid kinase activity by disrupting membrane-mediated dimerization.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Structural basis for high-affinity inhibitor binding to lipid kinases PIP4K2A and PIP4K2B.Acta crystallographica. Section D, Structural biology · 2026
    Article
  5. Targeting IPNature communications · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Distinct early role of PTEN regulation during HCMV infection of monocytes.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. The Silencing ofInternational journal of molecular sciences · 2024
    Article
  12. Identification and Analysis of the Expression of theInternational journal of molecular sciences · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Structural basis of membrane recognition ofLife science alliance · 2022
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yagmur MuftuogluDepartment of Pharmacology, Yale School of Medicine, New Haven, CT 06520;
Yi XueDepartment of Pharmacology, Yale School of Medicine, New Haven, CT 06520;
Xiang GaoDepartment of Pharmacology, Yale School of Medicine, New Haven, CT 06520; Department of Neurosurgery and Institute of Neurosurgery, State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China.
Dianqing WuDepartment of Pharmacology, Yale School of Medicine, New Haven, CT 06520;
Ya HaDepartment of Pharmacology, Yale School of Medicine, New Haven, CT 06520; ya.ha@yale.edu.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Life Science and Biomedical technology Research center at NSLS-II LSBRP41GM111244 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MCSWEENEY, SEAN · 2014 to 2018
$16.4M
Mechanisms for Wnt SignalingR01GM112182 · NIGMS · YALE UNIVERSITY · PI HA, YA, WU, DIANQING · 2014 to 2018
$1.5M
NCATS NIH HHS UL1 TR001863NIGMS NIH HHS P41 GM111244NIGMS NIH HHS R01 GM112182
6 · The paper itself

Abstract

The phosphatidylinositol phosphate kinase (PIPK) family of enzymes is primarily responsible for converting singly phosphorylated phosphatidylinositol derivatives to phosphatidylinositol bisphosphates. As such, these kinases are central to many signaling and membrane trafficking processes in the eukaryotic cell. The three types of phosphatidylinositol phosphate kinases are homologous in sequence but differ in catalytic activities and biological functions. Type I and type II kinases generate phosphatidylinositol 4,5-bisphosphate from phosphatidylinositol 4-phosphate and phosphatidylinositol 5-phosphate, respectively, whereas the type III kinase produces phosphatidylinositol 3,5-bisphosphate from phosphatidylinositol 3-phosphate. Based on crystallographic analysis of the zebrafish type I kinase PIP5Kα, we identified a structural motif unique to the kinase family that serves to recognize the monophosphate on the substrate. Our data indicate that the complex pattern of substrate recognition and phosphorylation results from the interplay between the monophosphate binding site and the specificity loop: the specificity loop functions to recognize different orientations of the inositol ring, whereas residues flanking the phosphate binding Arg244 determine whether phosphatidylinositol 3-phosphate is exclusively bound and phosphorylated at the 5-position. This work provides a thorough picture of how PIPKs achieve their exquisite substrate specificity.

Indexed as

AnimalsBinding SitesCrystallography, X-RayModels, MolecularPhosphatidylinositol PhosphatesPhosphatidylinositolsPhosphorylationPhosphotransferases (Alcohol Group Acceptor)Protein BindingProtein DomainsSubstrate SpecificityZebrafish Proteins1-phosphatidylinositol-4-phosphate 5-kinasephosphatidylinositol 3-phosphatePhosphatidylinositol PhosphatesPhosphatidylinositolsPhosphotransferases (Alcohol Group Acceptor)Zebrafish Proteinscrystallographylipid kinasesprotein engineeringsubstrate specificity

Identifiers

PMID27439870
PMCPMC4978281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.